Financial News
Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data
October 13, 2022 at 10:55 AM EDT
The FDA has authorized Pfizer's boosters without direct human data on how they perform against the omicron BA.5 subvariant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
